Fred Schwaller

Fred Schwaller is a writer, editor and storyteller with a focus on the human body and mind. He explores where science influences society in history and into the future. With a PhD in neuroscience, he has an in-depth understanding of the field which he uses to craft engaging narratives for his readers. His work can be found at DW News.

Biography:  https://www.dw.com/en/fred-schwaller/person-60733223

100%

The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermines the credibility of the source. It is calculated as:
Analysis.OverallConflictOfInterestScore * 0.3F + Analysis.OverallBiasScore * 0.3F + Analysis.DeceptivenessScore * 0.3F + Analysis.ReadabilityScore * 0.1F

A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

The Daily's Verdict

This author is known for its high journalistic standards. The author strives to maintain neutrality and transparency in its reporting, and avoids conflicts of interest. The author has a reputation for accuracy and rarely gets contradicted on major discrepancies in its reporting.

Bias

100%

Examples:

No current examples available.

Conflicts of Interest

100%

Examples:

No current examples available.

Contradictions

95%

Examples:

  • 11 out of 14 participants experienced improved vision without serious adverse side effects.
  • Inherited retinal degenerations are a leading cause of blindness around the world.
  • Participants received a single dose of CRISPR gene therapy called EDIT-101, which cuts out the mutation in CEP290 and replaces it with a healthy strand of DNA, restoring normal function of the protein and allowing the retina to detect light.
  • The gene-editing tool CRISPR was found to be safe and efficacious in improving vision among most patients in the clinical trial.
  • The study was the first to use gene therapy to treat children born with a form of blindness.

Deceptions

100%

Examples:

No current examples available.

Recent Articles

CRISPR Gene Therapy Restores Vision for 11 of 14 Participants with Inherited Blindness in Landmark Clinical Trial

CRISPR Gene Therapy Restores Vision for 11 of 14 Participants with Inherited Blindness in Landmark Clinical Trial

Broke On: Monday, 06 May 2024 A groundbreaking clinical trial led by Mass Eye and Ear's Eric Pierce, MD, Ph.D., has shown promising results in restoring vision for individuals with Leber Congenital Amaurosis (LCA) using CRISPR-Cas9 gene editing. The study demonstrated the safety and effectiveness of EDIT-101 in correcting the CEP290 gene mutation, improving vision for 11 out of 14 participants without serious side effects. This marks a significant milestone in treating inherited blindness using gene editing techniques, with similar results reported from Children's Hospital of Philadelphia and Missouri State University.